Cirtuvivint
- Generic Name
- Cirtuvivint
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C24H25N7O
- CAS Number
- 2143917-62-6
- Unique Ingredient Identifier
- 7T1PY32ZPH
- Background
Cirtuvivint is a first-in-class CDC-like kinase (CLK) inhibitor.
- Associated Conditions
- -
- Associated Therapies
- -
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 and ASTX727 With Venetoclax to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 48
- Registration Number
- NCT06484062
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath